Gregory Romaniuk

Gregory Romaniuk practices at St. Luke's Nampa Medical Center in Nampa, Idaho, part of St. Luke's Health System.

Gregory Romaniuk's NPI, 1144246729, was assigned on July 15, 2006. Gregory Romaniuk holds Idaho license M-165550.

Gregory Romaniuk's primary practice is St. Luke's Nampa Medical Center, at 9850 West St Lukes Drive, Nampa, ID 83687 in Canyon County. The practice phone is (208) 505-2000.

Gregory Romaniuk's primary practice is St. Luke's Nampa Medical Center in Nampa, Idaho, part of St. Luke's Health System. Gregory Romaniuk is also affiliated with St. Luke's Boise Medical Center. The medical group on file is St. Luke's Health System. Dmand AI also links Gregory Romaniuk to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gregory Romaniuk practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Gregory Romaniuk's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Gregory Romaniuk's licenses on file in 4 states: Idaho, Florida, Kentucky and South Carolina.

CMS data shows 392 Medicare services from Gregory Romaniuk across 5 procedure codes in 2024, for 173 Medicare patients. Medicare paid $33,418 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Gregory Romaniuk in 2024. The largest group is 75 to 84, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gregory Romaniuk's median patient age at 70, with 58% women.

In 2024, Gregory Romaniuk wrote 172 Medicare Part D claims for 74 patients. 91% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $38 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Gregory Romaniuk for performance year 2024, reported as part of a group. Gregory Romaniuk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Gregory Romaniuk from 5 drug and device companies from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $112.